Private Wealth Management Group’s Agios Pharmaceuticals AGIO Stock Holding History

Private Wealth Management Group’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.08K	Hold	83	–	–	﹤0.01%	1024
2026 Q1	$2.81K	Hold	83	–	–	﹤0.01%	970
2025 Q4	$2.26K	Sell	83 -1	-1%	-$35	﹤0.01%	1044
2025 Q3	$3.37K	Hold	84	–	–	﹤0.01%	937
2025 Q2	$2.79K	Hold	84	–	–	﹤0.01%	977
2025 Q1	$2.46K	Hold	84	–	–	﹤0.01%	988
2024 Q4	$2.76K	Hold	84	–	–	﹤0.01%	972
2024 Q3	$3.73K	Hold	84	–	–	﹤0.01%	839
2024 Q2	$3.62K	Hold	84	–	–	﹤0.01%	843
2024 Q1	$2.46K	Hold	84	–	–	﹤0.01%	885
2023 Q4	$1.87K	Buy	+84	New	+$1.88K	﹤0.01%	1010

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Private Wealth Management Group's AGIO Position: Q2 2026 in Review

Private Wealth Management Group held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 83 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Private Wealth Management Group first reported a position in AGIO in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.73K in Q3 2024. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

Private Wealth Management Group held 83 shares of Agios Pharmaceuticals worth $3.08K as of Q2 2026.
Private Wealth Management Group left its Agios Pharmaceuticals share count unchanged in Q2 2026.
Agios Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #1024 holding.
Private Wealth Management Group first reported a position in Agios Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Private Wealth Management Group's Agios Pharmaceuticals position peaked at $3.73K in Q3 2024.
239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.